Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03409159

Austrian Left Atrial Appendage Closure Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Conditions

Interventions

TypeNameDescription
DEVICELAACLeft atrial appendage closure

Timeline

Start date
2017-05-16
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2018-01-24
Last updated
2024-11-21

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03409159. Inclusion in this directory is not an endorsement.

Austrian Left Atrial Appendage Closure Registry (NCT03409159) · Clinical Trials Directory